- Investing Ideas
- Chinese Biotech Breakthroughs
Chinese Biotech Breakthroughs
Results
4
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
4 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥26.4b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥56.70
7D
2.0%
1Y
-2.1%
Nanjing Vazyme Biotech
Market Cap: CN¥7.9b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥19.95
7D
3.9%
1Y
-9.6%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥10.9b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥29.62
7D
-5.8%
1Y
4.1%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥27.5b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥104.00
7D
7.1%
1Y
-3.8%